Mitotech Company

Mitotech is focused on rapid development of break-through pharmaceutical products based on mitochondria targeted antioxidants. The unique experimentally proved properties of these molecules make them promising drug candidates for treatment of many age-related disorders. Mitotech is developing its technology with a goal to help millions of patients suffering from ophthalmic, neurodegenerative, cardiovascular, metabolic and rare genetic disorders.
Technology: Biologics
Industry: Small&Large Molecules
Headquarters: Luxembourg, Luxembourg, Luxembourg
Founded Date: 2009
Employees Number: 1-10
Total Funding: $990K
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership